跳至主要内容
临床试验/NCT06466746
NCT06466746尚未招募不适用

The Impact of Faba Bean Rich Bread on Iron Status, Postprandial Lipaemia and Satiety in Adults With Low Iron Stores

University of Reading2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2024年6月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
16
试验地点
2
主要终点
Change from baseline in the enrichment of whole blood haemoglobin with iron-57 stable isotope 30 days after consuming the faba bean-enriched bread and conventional bread.

研究概览

简要总结

High levels of animal proteins (meat) in the diet are linked with a greater risk of developing heart disease and other long-term health conditions. Recently there has been a shift to plant-based diets including plant proteins such as pulses, defined as beans, peas, chickpeas and lentils. Pulses are a nutritious and sustainable form of plant protein which are rich in fibre and iron. Despite this, the UK population does not consume the recommended daily amount of pulses (80g/day equivalent to a large handful). In contrast, bread is commonly consumed but very little is known about how bread enriched with pulses influences the amount of iron that is digested and absorbed by the body as well as risk factors for developing heart disease and type 2 diabetes.

The main purpose of this randomised controlled cross-over study is to determine how consuming bread enriched with pulses (in the form of faba bean flour at approximately 40% enrichment) compared with conventional white bread (100% wheat flour) influences the amount of iron absorbed in healthy males and females aged 18-50 years with low iron stores. Secondary aims are determining the effects on blood fats and sugar (glucose) and on feelings of fullness (also known as satiety) after eating the bread enriched in pulses and conventional white bread.

Participants will be required:

  • To attend for seven study visits over a period of 60 days.
  • Consume a breakfast meal containing either the faba bean-enriched bread or conventional bread over two study periods, each consisting of one 7 hour study visit and two consecutive visits of 2 hours in duration. After 28 days, participants will return for the second study period as above, with a final study visit conducted 28 days later.
  • Give blood samples during 2 x 7 hour study visits
  • Complete visual analogue scales to rate appetite after consuming the faba bean-enriched and conventional white bread.
  • Record dietary intake prior to and during the study period.

详细描述

Since higher dietary intakes of animal protein (meat) are linked with heart disease and other long-term health problems, there has been a shift in recent years to consuming more plant-based foods. Legumes (e.g. beans) provide a sustainable and nutritious source of protein and are higher in fibre and micronutrients (such as iron) compared with staple cereals. Higher intakes of pulses lower blood sugar and fat levels, increase feelings of fullness (satiety) and reduce blood pressure. The higher iron content in mature faba beans may also help to reduce iron-deficiency anaemia, the most common diet-related deficiency. However, studies have suggested that the absorption of iron from pulses (known as bioavailability) is lower than from meat due to the presence of compounds in plants that interfere with absorption (anti-nutrients). Processing techniques such as milling of faba beans are considered to lower or even eliminate these compounds. In the Raising the Pulse (RtP) project, flour milled from homegrown faba beans will be used to produce a pulse-enriched loaf which could be adopted in the UK diet and benefit both health and the environment. However, very little is known about how bread enriched with pulses may influence firstly, iron bioavailability and secondly, blood sugar and fat levels which are common risk factors for developing heart disease and diabetes.

This randomised controlled cross-over study will aim to recruit 16 healthy, non-anaemic males and females with low iron stores. Aside from the screening visit where participants will be assessed for eligibility and consent for participation gained, this study will involve seven study visits. The first study visit (Day 1) will be approximately 7 hours (420 minutes) in duration and participants will be randomly assigned to consume either the faba bean-enriched bread or the conventional white bread along with a drink containing iron-57, a naturally occurring non-radioactive form of iron found in very low levels in the diet (stable isotope) to measure iron absorption. Blood samples will be collected to measure blood haemoglobin, sugar and fat levels as well as hormones known to impact appetite, and participants will be asked to complete visual analogue scales to rate their appetite. At the visit, an ad-libitum (unrestricted) meal will be provided 6 hours after eating the test breakfast and the amount of food eaten will be used to assess satiety. Participants will then return on days 2 and 3 to consume the same test meal and complete visual analogue scales to rate appetite for 2 hours. At day 30, participants will return for the second 7 hour (420 minute) study visit to consume the other type of bread and return on days 31 and 32 for the shorter study visits. The day 30 fasting blood sample will be used to measure the enrichment of blood haemoglobin with iron-57 to determine the amount of iron absorbed from the test bread given on day 0. On day 60, participants will return to the clinical unit to give a final fasting blood sample to measure iron bioavailability (enrichment of blood haemoglobin with iron-57) from the test bread given on day 30. Dietary intake will also be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Non-anaemic, males and pre-menopausal females (must have regular periods)
  • Aged 18-50 years old
  • BMI between 19 - 30 kg/m2
  • Low iron stores (serum ferritin between 13-40 µg/L for females and 30-90 µg/L for males)

排除标准

  • Food allergies or intolerances to faba beans (favism) or gluten
  • Diagnosed with anaemia (haemoglobin <115 g/L for females or <130 g/L for males) or haemochromatosis
  • C-reactive protein (>3mg/L)
  • A history of alcohol abuse (> 14 units/ week)
  • CVD or medical history of MI or stroke in the past 12 months
  • Diabetes (fasting glucose >7.0 mmol/L)
  • Kidney, liver, pancreas or intestinal disease, gastrointestinal disorder or use of drugs likely to alter gastrointestinal function
  • Pregnancy, planning a pregnancy in the next six months or breastfeeding
  • Peri- and post-menopausal women or women with irregular periods
  • Planning on a weight-reducing regimen (lost >3kg in last 6 months)
  • Parallel participation in another intervention study
  • Hypertension (blood pressure > 140/90 mmHg), cancer, taking medication for hyperlipidaemia (statins), or inflammation
  • Taking vitamin or mineral supplements
  • Donated blood in the last 3 months
  • Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention and metabolic study (such as a pacemaker)

结局指标

主要结局

Change from baseline in the enrichment of whole blood haemoglobin with iron-57 stable isotope 30 days after consuming the faba bean-enriched bread and conventional bread.

时间窗: Day 0 (baseline), day 30 and day 60

The measurement of iron-57 in whole blood is a validated method for determining the absorption of iron from the bread given in the test meals (also known as bioavailability)

次要结局

  • Body mass index calculation(Day 0 (baseline), day 30 and day 60)
  • Waist and hip circumferences(Day 0 (baseline), day 30 and day 60)
  • Fasting concentrations of iron status markers(Day 0 (baseline), day 30 and day 60)
  • Fasting levels of the full blood count parameters(Day 0 (baseline), day 30 and day 60)
  • Fasting estimate of insulin sensitivity(Day 0 (baseline), day 30 and day 60)
  • Postprandial glucose concentrations after consuming the faba bean-enriched bread and control bread.(Acute study on Days 0 and 30, blood taken prior to eating the test meal (0 minutes) and then at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes post meal ingestion)
  • Fasting low-density lipoprotein-cholesterol concentration(Day 0 (baseline), day 30 and day 60)
  • Postprandial concentrations of lipids after consuming the faba bean-enriched bread and control bread.(Acute study on Days 0 and 30, blood taken prior to eating the test meal (0 minutes) and then at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes post meal ingestion.)
  • Postprandial insulin concentrations after consuming the faba bean-enriched bread and control bread.(Acute study on Days 0 and 30, blood taken prior to eating the test meal (0 minutes) and then at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes post meal ingestion)
  • Fasting apolipoprotein B concentration(Day 0 (baseline), day 30 and day 60)
  • Postprandial apolipoprotein B concentrations after consuming the faba bean-enriched bread and control bread.(Acute study on Days 0 and 30, blood taken prior to eating the test meal (0 minutes) and then at 60, 120, 180, 240, 300 and 360 minutes post meal ingestion.)
  • Height(Day 0 (baseline))
  • Body fat percentage(Day 0 (baseline), day 30 and day 60)
  • Body fat mass and lean mass(Day 0 (baseline), day 30 and day 60)
  • Clinic blood pressure(Day 0 (baseline), day 30 and day 60)
  • Fasting blood samples stored for future ethically approved research related to the project aims and objectives.(Day 0 (baseline), day 30 and day 60)
  • Fasting estimate of insulin resistance(Day 0 (baseline), day 30 and day 60)
  • Fasting concentration of C-reactive protein (a marker of inflammation)(Day 0 (baseline), day 30 and day 60)
  • Fasting concentration of total cholesterol, high-density lipoprotein-cholesterol, triacylglycerol and non-esterified fatty acids.(Day 0 (baseline), day 30 and day 60)
  • Fasting glucose concentration(Day 0 (baseline), day 30 and day 60)
  • Fasting insulin concentration(Day 0 (baseline), day 30 and day 60)
  • Fasting and postprandial concentrations of gut hormones(Acute study on Days 0 and 30, blood taken before meal ingestion at 0 minutes and then at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes post meal ingestion)
  • Fasting and postprandial concentrations of amino acids(Acute study on Days 0 and 30, blood taken before eating the test meal (0 minutes) and then at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes post meal ingestion)
  • Body weight(Day 0 (baseline), day 30 and day 60)
  • Postprandial feelings of satiety_7 hour study visit (long day)(Acute study on Days 0 and 30, prior to eating the test meal (0 minutes) and then at 15, 30, 60, 120, 240 and 360 minutes post meal ingestion)
  • Postprandial feelings of satiety_2 hour study visit (short day)(Days 1, 2, 31 and 32 prior to eating the test meal (0 minutes) and then at 15, 30, 60 and 120 minutes post meal ingestion.)
  • Habitual dietary intake of the study participants(Day 0 (baseline), day 30 and day 60)
  • Postprandial blood samples stored for future ethically approved research related to the study aims and objectives.(Acute study on Days 0 and 30, blood taken prior to eating the test meal (0 minutes) and then at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360 minutes post meal ingestion.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie Lovegrove

Professor of Human Nutrition and Director of the Hugh Sinclair Unit of Human Nutrition

University of Reading

研究点 (2)

Loading locations...

相似试验